Gro Janne Wergeland

Gro Janne Wergeland

Auto-generated profile, based on publicly available information

Gro Janne Wergeland

Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
GWGro Janne H. Wergeland
Gro Janne H. Wergeland
KFKrister W Fjermestad
Krister W Fjermestad
CMCarla E. Marin
Carla E. Marin
BHBente Storm Mowatt Haugland
Bente Storm Mowatt Haugland
JBJon Fauskanger Bjaastad
Jon Fauskanger Bjaastad
EHEinar R. Heiervang
Einar R. Heiervang

1 February 2021 in Clinical Psychology Review
Verified
Journal Article
Open access
GWGro Janne H. Wergeland
Gro Janne H. Wergeland
EREili N. Riise
Eili N. Riise
LÖLars-Göran Öst
Lars-Göran Öst
Cognitive behavioral therapy (CBT) has received considerable empirical support for internalizing disorders including anxiety, depression, obsessive-compulsive disorder, and post-traumatic stress disorder in children and adolescents. However, there is less knowledge regarding how CBT performs when delivered in routine clinical care. A systematic review and meta-analysis was conducted of CBT for internalizing disorders in children and adolescents in routine clinical care. Ovid MEDLINE, Embase OVID, and PsycINFO were systematically searched for articles published until October 2019. The effectiveness of CBT, methodological quality, and moderators of treatment outcome were examined. The effects of CBT in routine clinical care were benchmarked by comparing with efficacy studies for the same disorders. Fifty-eight studies were included, comprising 4618 participants. Large effect sizes for outcome were detected at post-treatment (g = 1.28-2.54), and follow-up (g = 1.72-3.36). Remission rates across diagnoses ranged from 50.7% - 77.4% post-treatment, to 53.5% -83.3% at follow-up. Attrition rate across the disorders was 12.2%. Quality of the included studies was fair, and heterogeneity was high. Similarities between the effectiveness and efficacy studies were greater than the differences in outcome. CBT delivered in routine clinical care is efficacious in reducing internalizing disorders and symptoms. The outcomes are comparable with results obtained in efficacy studies. PROSPERO registration: ID CRD42019128709.

19 July 2020 in Journal of Child Psychology and Psychiatry
Verified
Journal Article
Open access
PDF file
CCCathy Creswell
Cathy Creswell
MNMaaike H. Nauta
Maaike H. Nauta
JHJennifer L. Hudson
Jennifer L. Hudson
SMSonja March
Sonja March
TRTessa Reardon
Tessa Reardon
PKPhilip C. Kendall
Philip C. Kendall
Background: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies’ outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor‐based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). Methods: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. Results and Conclusions: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward.

2 August 2022 in Behaviour Research and Therapy
Verified
Journal Article
Open access
LÖLars-Göran Öst
Lars-Göran Öst
PEPia Enebrink
Pia Enebrink
AFAnna Finnes
Anna Finnes
Ata GhaderiAta Ghaderi
Ata Ghaderi
AHAudun Havnen
Audun Havnen
GWGro Janne Wergeland
Gro Janne Wergeland
Cognitive behavioral therapy (CBT) has strong research support for obsessive-compulsive disorder (OCD). However, less is known about how CBT performs when delivered in routine clinical care. A systematic review and meta-analysis was conducted of CBT for OCD in adults treated in routine clinical care. Ovid MEDLINE, Embase OVID, and PsycINFO were systematically searched for studies published until July 2021. The effectiveness of CBT, methodological quality, and moderators of treatment outcome were examined, and benchmarked by meta-analytically comparing with efficacy studies for OCD. Twenty-nine studies (8 randomized controlled trials) were included, comprising 1669 participants. Very large within-group effect sizes (ES) were obtained for OCD-severity at post-treatment (2.12), and follow-up (2.30), on average 15 months post-treatment. Remission rates were 59.2% post-treatment and 57.0% at follow-up. Attrition rate was 15.2%. Risk of bias was considerable in the majority of studies. The benchmarking analysis showed that effectiveness studies had almost exactly the same ES as efficacy studies at post-treatment and somewhat higher at follow-up. Furthermore, effectiveness studies had significantly higher remission rates than efficacy studies, both at post- and follow-up assessment. CBT for OCD is an effective treatment when delivered in routine clinical care, with ES comparable to those found in efficacy studies. However, the evidence needs to be interpreted with caution because of the risk of bias in a high proportion of studies. PROSPERO REGISTRATION ID: CRD42021228828.

1 April 2020 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
BHBente Storm Mowatt Haugland
Bente Storm Mowatt Haugland
ÅHÅshild Tellefsen Haaland
Åshild Tellefsen Haaland
VBValborg Baste
Valborg Baste
JBJon Fauskanger Bjaastad
Jon Fauskanger Bjaastad
AHAsle Hoffart
Asle Hoffart
GWGro Janne Wergeland
Gro Janne Wergeland
We examined the effectiveness of targeted school-based cognitive-behavioral therapy (CBT) for adolescents (12-16 years of age) with anxiety, and tested whether brief CBT was noninferior to standard duration CBT. A randomized controlled study of 313 adolescents (mean 14.0 years, SD = 0.84, 84% girls) were recruited through school health services to 10 weeks CBT group interventions. Groups of 5 to 8 adolescents were randomly allocated to brief (5 sessions, comprising 5.5 hours) or standard CBT (10 sessions, comprising 15 hours), or 10 weeks waitlist (WL). Self-reported and parent-reported youth anxiety symptoms, impairment from anxiety, depressive symptoms,and clinical severity were assessed pre- and postintervention, after WL, and at 1-year follow-up. Targeted school based CBT significantly reduced adolescents' anxiety symptoms with small to moderate effect sizes compared to WL (Cohen d = 0.34 for youth report and d = 0.53 for parent report). According to the parents, also adolescents' impairment from anxiety was significantly reduced compared to WL (d = 0.51). Pre to post changes in anxiety symptoms were small to moderate (within-group effect sizes between d = 0.41 and d = 0.67). Although no significant differences in effects were found between brief and standard CBT, brief CBT was not noninferior to standard CBT. Outcomes from both interventions were sustained at 1-year follow-up. Targeted school-based CBT interventions reduced anxiety, impairment, and depressive symptoms in adolescents. Both brief and standard CBT demonstrated efficacy, but brief CBT was not noninferior to standard CBT. By administering school-based CBT to youths with anxiety symptoms, we may reach young people with effective interventions at an earlier phase in their lives. School Based Low-intensity Cognitive Behavioral Intervention for Anxious Youth (LIST); http://clinicalrials.gov/; NCT02279251.

1 January 2016 in Behaviour Research and Therapy
Verified
Journal Article
Closed access
GWGro Janne H. Wergeland
Gro Janne H. Wergeland
KFKrister W. Fjermestad
Krister W. Fjermestad
CMCarla E. Marin
Carla E. Marin
IBIngvar Bjelland
Ingvar Bjelland
BHBente Storm Mowatt Haugland
Bente Storm Mowatt Haugland
EHEinar R. Heiervang
Einar R. Heiervang